当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

4.22

-0.08  (-1.86%)

今开:4.26最高:4.28成交:1.92万手 市盈:0.00 上证指数:2941.62   -0.43%2019-10-23
昨收:4.30 最低:4.21 换手:0.00%振幅:0.00 深证指数:9567.75  -0.77%15:02:39

集合

竞价

现金流量表

按照会计年度查询:
报告期2019-06-302018-12-312018-09-302018-06-30
一、经营活动产生的现金流量
销售商品、提供劳务收到的现金17,512,798,502.2931,944,910,052.2421,735,766,654.4114,214,909,467.6
收到的税费返还--------
收到其他与经营活动有关的现金2,098,777,176.482,417,584,371.161,681,041,864.91,180,758,559.81
经营活动现金流入小计19,611,575,678.7734,362,494,423.423,416,808,519.3115,395,668,027.41
购买商品、接受劳务支付的现金17,896,433,773.2131,443,516,00622,759,217,572.4314,516,218,742.04
支付给职工以及为职工支付的现金364,722,166.77638,244,070.52477,219,705.14304,209,562.8
支付的各项税费273,665,648.14467,839,738.49325,868,761.41239,618,582.17
支付其他与经营活动有关的现金2,628,334,891.032,179,796,149.491,090,475,289.391,047,426,015.27
经营活动现金流出小计21,163,156,479.1534,729,395,964.524,652,781,328.3716,107,472,902.28
经营活动产生的现金流量净额-1,551,580,800.38-366,901,541.1-1,235,972,809.06-711,804,874.87
二、投资活动产生的现金流量
收回投资收到的现金400,0001,267,000----
取得投资收益收到的现金26,492.4204,272.54----
处置固定资产、无形资产和其他长期
资产收回的现金净额
701,126.21103,398,768.7102,549,168.5168,445,719.13
处置子公司及其他营业单位收到的现金净额--------
收到其他与投资活动有关的现金------150,000
投资活动现金流入小计1,127,618.61104,870,041.24102,549,168.5168,595,719.13
购建固定资产、无形资产和其他长期资产支付的现金133,059,125.14311,519,738.05198,566,821.04107,121,997.95
投资支付的现金--400,000400,000400,000
取得子公司及其他营业单位支付的现金净额60,196,882.9211,404,210.2711,404,210.27--
支付其他与投资活动有关的现金--------
投资活动现金流出小计193,256,008.06323,323,948.32210,371,031.31107,521,997.95
投资活动产生的现金流量净额-192,128,389.45-218,453,907.08-107,821,862.8-38,926,278.82
三、筹资活动产生的现金流量
吸收投资收到的现金--------
子公司吸收少数股东投资收到的现金--------
取得借款收到的现金8,932,231,158.2111,085,538,070.338,830,711,5007,021,081,902.01
收到其他与筹资活动有关的现金--------
发行债券收到的现金399,700,0004,598,081,9443,599,456,9441,000,000,000
筹资活动现金流入小计9,331,931,158.2116,614,568,569.7913,361,116,999.468,951,730,457.47
偿还债务支付的现金7,700,550,073.4214,370,459,143.2911,311,078,009.997,138,699,336.52
分配股利、利润或偿付利息支付的现金223,562,353.86424,248,518.62378,060,744.79290,931,655.42
子公司支付给少数股东的股利--------
支付其他与筹资活动有关的现金516,000336,744,2005,750,0005,750,000
筹资活动现金流出小计7,924,628,427.2815,131,451,861.9111,694,888,754.787,435,380,991.94
筹资活动产生的现金流量净额1,407,302,730.931,483,116,707.881,666,228,244.681,516,349,465.53
四、现金及现金等价物净增加额
汇率变动对现金的影响--------
现金及现金等价物净增加额-336,406,458.9897,761,259.7322,433,572.82765,618,311.84
期初现金及现金等价物余额2,255,408,6041,357,647,344.31,277,901,993.571,277,901,993.57
期末现金及现金等价物余额1,919,002,145.12,255,408,6041,600,335,566.392,043,520,305.41
补充资料:
1、将净利润调节为经营活动的现金流量:
净利润206,310,772.89345,831,988.76--173,913,263.91
加:资产减值准备21,148,683.089,832,796.8--6,524,117.41
固定资产折旧、油气资产折耗、生产性生物资产折旧49,574,619.6681,397,365.26--37,646,997.02
无形资产摊销5,629,451.4815,966,239.04--7,647,349.87
长期待摊费用摊销13,621,530.1929,619,500.78--12,542,150.36
待摊费用减少--------
预提费用增加--------
处置固定资产、无形资产和其他长期资产的损失19,709.51-33,873,396.46---110,088.91
固定资产报废损失--------
公允价值变动损失--------
财务费用183,465,692.32314,256,875.86--173,392,139.29
投资损失83,464.574,241,523.01---105,759.8
递延所得税资产减少7,923,767.375,328,611.03--9,026,539.55
递延所得税负债增加-5,909,937.88224,923.47---280,201.88
存货的减少-481,437,021.01-91,224,070.57---172,179,993.67
经营性应收项目的减少-1,922,004,419.21-1,903,021,586.44---1,404,557,109.1
经营性应付项目的增加370,531,373.52855,477,559.79--445,170,855.67
未确认的投资损失--------
其他-538,486.87-959,871.43---435,134.59
经营活动产生的现金流量净额-1,551,580,800.38-366,901,541.1---711,804,874.87
2、债务转为资本--------
3、一年内到期的可转换公司债券--------
4、融资租入固定资产--------
5、现金及现金等价物净增加情况:
现金的期末余额1,919,002,145.12,255,408,604--2,043,520,305.41
减:现金的期初余额2,255,408,6041,357,647,344.3--1,277,901,993.57
现金等价物的期末余额--------
减:现金等价物的期初余额--------
现金及现金等价物净增加额-336,406,458.9897,761,259.7--765,618,311.84
TOP↑